Meyka Pro banner
tella, Inc.

tella, Inc. Fundamental Analysis (JPX: 2191.T)

2191.TJPX
HealthcareBiotechnology
¥2.00
¥2.00(50.00%)
Japanese Market opens in 10h 48m

tella, Inc. Fundamental Analysis (JPX: 2191.T)

tella, Inc. (JPX: 2191.T) shows weak financial fundamentals with a PE ratio of -0.06, profit margin of -8.92%, and ROE of -1.44%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.01
Current Ratio5.18

Areas of Concern

ROE-1.44%
Operating Margin-7.46%
We analyze 2191.T's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -1032.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-1032.6/100

We analyze 2191.T's fundamental strength across five key dimensions:

Efficiency Score

Weak

2191.T struggles to generate sufficient returns from assets.

ROA > 10%
-2.91%

Valuation Score

Excellent

2191.T trades at attractive valuation levels.

PE < 25
-0.06
PEG Ratio < 2
-0.01

Growth Score

Weak

2191.T faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

2191.T maintains a strong and stable balance sheet.

Debt/Equity < 1
0.01
Current Ratio > 1
5.18

Profitability Score

Weak

2191.T struggles to sustain strong margins.

ROE > 15%
-144.19%
Net Margin ≥ 15%
-8.92%
Positive Free Cash Flow
N/A

Key Financial Metrics

Is 2191.T Expensive or Cheap?

P/E Ratio

2191.T trades at -0.06 times earnings. This suggests potential undervaluation.

-0.06

PEG Ratio

When adjusting for growth, 2191.T's PEG of -0.01 indicates potential undervaluation.

-0.01

Price to Book

The market values tella, Inc. at 0.29 times its book value. This may indicate undervaluation.

0.29

EV/EBITDA

Enterprise value stands at -0.06 times EBITDA. This is generally considered low.

-0.06

How Well Does 2191.T Make Money?

Net Profit Margin

For every $100 in sales, tella, Inc. keeps $-8.92 as profit after all expenses.

-8.92%

Operating Margin

Core operations generate -7.46 in profit for every $100 in revenue, before interest and taxes.

-7.46%

ROE

Management delivers $-1.44 in profit for every $100 of shareholder equity.

-1.44%

ROA

tella, Inc. generates $-2.91 in profit for every $100 in assets, demonstrating efficient asset deployment.

-2.91%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-28.69 in free cash annually.

$-28.69

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.06

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.01

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.29

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.01

vs 25 benchmark

Current Ratio

Current assets to current liabilities

5.18

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-1.44

vs 25 benchmark

ROA

Return on assets percentage

-2.91

vs 25 benchmark

ROCE

Return on capital employed

-2.95

vs 25 benchmark

How 2191.T Stacks Against Its Sector Peers

Metric2191.T ValueSector AveragePerformance
P/E Ratio-0.0632.14 Better (Cheaper)
ROE-144.19%550.00% Weak
Net Margin-891.62%30133.00% Weak
Debt/Equity0.010.56 Strong (Low Leverage)
Current Ratio5.185.70 Strong Liquidity
ROA-290.67%3.00% Weak

2191.T outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews tella, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ